TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BOLD: A Trial of Blood Pressure Lowering in Dialysis
Brief Summary: Blood pressure may be one of the most important modifiable risk factors for cardiovascular disease in patients with end-stage-renal-disease undergoing maintenance hemodialysis. Although a systolic blood pressure \<140 mmHg treatment target has been recommended, there remains uncertainty on which blood pressure should be targeted, more specifically that measured in the dialysis unit or at home. Observational studies have reported a paradoxical U-shaped associated with dialysis unit (pre-dialysis) systolic blood pressure and cardiovascular events and death (where blood pressure below 140 mmHg is actually linked with poor outcomes). Conversely, the same studies have reported a linear association between higher home systolic blood pressure and worse clinical outcomes, where blood pressure below 140 mmHg is associated with better outcomes. This pilot clinical trial aims to address this important question.


Options:
A: Arm Label: Home systolic blood pressure (SBP) <140 mmHg; Type: EXPERIMENTAL; Interventions: Drug: Anti-Hypertensive medications, Procedure: Dry Weight Adjustment | Arm Label: Pre-dialysis SBP <140 mmHg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Anti-Hypertensive medications, Procedure: Dry Weight Adjustment | Intervention Type: DRUG; Name: Anti-Hypertensive medications; Assigned to Arm(s): Home systolic blood pressure (SBP) <140 mmHg, Pre-dialysis SBP <140 mmHg | Intervention Type: PROCEDURE; Name: Dry Weight Adjustment; Assigned to Arm(s): Home systolic blood pressure (SBP) <140 mmHg, Pre-dialysis SBP <140 mmHg
B: Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Drug: darbepoetin alfa | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: darbepoetin alfa; Assigned to Arm(s): Active
C: Arm Label: Meditation Intervention Arm; Type: EXPERIMENTAL; Interventions: Other: Meditation | Arm Label: Control Group (No Meditation Exposure); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Meditation; Assigned to Arm(s): Meditation Intervention Arm
D: Arm Label: CBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia | Arm Label: Medication- Trazodone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Trazodone | Arm Label: Medication- Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Insomnia; Assigned to Arm(s): CBT-I | Intervention Type: DRUG; Name: Trazodone; Assigned to Arm(s): Medication- Trazodone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Medication- Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intravenous Infusion of Magnesium Sulphate on Arterial Oxygenation and Pulmonary Mechanics in Patients With Chronic Obstructive Pulmonary Diseases Undergoing Cancer Larynx Surgery. A Randomized Controlled Trial
Brief Summary: Chronic Obstructive Pulmonary Disease \[COPD\] is a major cause of chronic morbidity and mortality worldwide. COPD is characterized by persistent progressive airflow limitation that adversely affects the ventilation/perfusion (V/Q) matching and mechanics of the respiratory muscles and leads to hypoventilation and reduced gas transfer. COPD was identified as a significant comorbidity associated with increased incidences of postoperative pulmonary complications and prolonged hospital stay. MgSO4 either intravenous or inhalational has been shown to promote bronchodilation and to improve lung function in asthmatic patients. MgSO4 either intravenous or inhalational has been shown to promote bronchodilation and to improve lung function in asthmatic patients. Administration of MgSO4 in patients with stable COPD was associated with reduced lung hyperinflation and improvement of respiratory muscle strength. This randomized control trial is designed to assess the effect of intravenous MgSO4 infusion on oxygenation and pulmonary mechanics and incidence of postoperative pulmonary complications and length of hospital stay in patients with COPD undergoing cancer larynx surgery.


Options:
A: Intervention Type: DRUG; Name: Magnesium Sulfate 2 grams; Assigned to Arm(s): N/A
B: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls
C: Intervention Type: DRUG; Name: Salmeterol 50mcg/ Fluticasone Propionate 500mcg; Assigned to Arm(s): N/A
D: Arm Label: Mg-group; Type: EXPERIMENTAL; Interventions: Drug: Magnesium Sulphate | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Magnesium Sulphate; Assigned to Arm(s): Mg-group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of a Long-term Home-based Exercise Training Program Using Minimal Equipment vs. Usual Care in COPD Patients: a Multicenter Randomized Controlled Trial
Brief Summary: The aim of this study is to assess the effectiveness of a home-based exercise training program in COPD patients who have completed a pulmonary rehabilitation.


Options:
A: Arm Label: Exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise intervention
B: Arm Label: patients with COPD; Type: N/A; Interventions: N/A | Arm Label: smoking controls; Type: N/A; Interventions: N/A | Arm Label: non-smoking controls; Type: N/A; Interventions: N/A
C: Arm Label: MOBILE-A; Type: EXPERIMENTAL; Interventions: Behavioral: Coached exercise persistence intervention | Arm Label: MOBILE-B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Monitored exercise persistence intervention | Intervention Type: BEHAVIORAL; Name: Coached exercise persistence intervention; Assigned to Arm(s): MOBILE-A | Intervention Type: BEHAVIORAL; Name: Self-Monitored exercise persistence intervention; Assigned to Arm(s): MOBILE-B
D: Arm Label: Treatment sequence I; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVA149, Drug: Placebo | Arm Label: Treatment sequence II; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVA149, Drug: Placebo | Intervention Type: DRUG; Name: QVA149; Assigned to Arm(s): Treatment sequence I, Treatment sequence II | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Treatment sequence I, Treatment sequence II

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome.
Brief Summary: When patients suffer from chronic pain after multiple back surgeries, this is denominated as the 'failed back surgery syndrome'. A possible treatment for these patients is spinal cord stimulation. This is an invasive treatment where no other treatment options (medication, minimal invasive treaments) can offer progress to the patients' health status. In spinal cord stimulation, an electrode will be placed at the spinal cord under local anaesthesia whereas via a battery a painless electrical stimulation will arise. Clinical research have demonstrated that a new way of spinal cord stimulation can improve back and leg pain significantly. This will lead to a better quality of life for the patients and a decreased use of medications. In Ziekenhuis Oost-Limburg, different manners of spinal cord stimulation will be compared to each other.


Options:
A: Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): N/A
B: Arm Label: Burst SCS; Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Arm Label: Sham SCS; Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: DEVICE; Name: SCS implant; Assigned to Arm(s): Burst SCS, Sham SCS
C: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
D: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome.
Brief Summary: When patients suffer from chronic pain after multiple back surgeries, this is denominated as the 'failed back surgery syndrome'. A possible treatment for these patients is spinal cord stimulation. This is an invasive treatment where no other treatment options (medication, minimal invasive treaments) can offer progress to the patients' health status. In spinal cord stimulation, an electrode will be placed at the spinal cord under local anaesthesia whereas via a battery a painless electrical stimulation will arise. Clinical research have demonstrated that a new way of spinal cord stimulation can improve back and leg pain significantly. This will lead to a better quality of life for the patients and a decreased use of medications. In Ziekenhuis Oost-Limburg, different manners of spinal cord stimulation will be compared to each other.


Options:
A: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
B: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
C: Arm Label: Arthroscopic Sub-acromial Decompression; Type: EXPERIMENTAL; Interventions: Procedure: Arthroscopic Sub-acromial Decompression Surgery | Arm Label: Shoulder Arthroscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Shoulder Arthroscopy | Arm Label: Active Monitoring with Specialist Reassessment; Type: OTHER; Interventions: Other: Active Monitoring with Specialist Reassessment | Intervention Type: PROCEDURE; Name: Arthroscopic Sub-acromial Decompression Surgery; Assigned to Arm(s): Arthroscopic Sub-acromial Decompression | Intervention Type: PROCEDURE; Name: Shoulder Arthroscopy; Assigned to Arm(s): Shoulder Arthroscopy | Intervention Type: OTHER; Name: Active Monitoring with Specialist Reassessment; Assigned to Arm(s): Active Monitoring with Specialist Reassessment
D: Intervention Type: DEVICE; Name: Medtronic Manufactured Spinal Cord Stimulators; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome.
Brief Summary: When patients suffer from chronic pain after multiple back surgeries, this is denominated as the 'failed back surgery syndrome'. A possible treatment for these patients is spinal cord stimulation. This is an invasive treatment where no other treatment options (medication, minimal invasive treaments) can offer progress to the patients' health status. In spinal cord stimulation, an electrode will be placed at the spinal cord under local anaesthesia whereas via a battery a painless electrical stimulation will arise. Clinical research have demonstrated that a new way of spinal cord stimulation can improve back and leg pain significantly. This will lead to a better quality of life for the patients and a decreased use of medications. In Ziekenhuis Oost-Limburg, different manners of spinal cord stimulation will be compared to each other.


Options:
A: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental
C: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
D: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Spinal Cord Stimulation | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Spinal Cord Stimulation; Assigned to Arm(s): Spinal Cord Stimulation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans
Brief Summary: The purpose of this study is to conduct a pilot randomized controlled trial (RCT) with low-income, suicidal African American women and men that compares the relative effectiveness of compassion meditation (CM) versus a support group (SG) .


Options:
A: Arm Label: Ketamine; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of ketamine, Other: Follow-up between perfusions, Drug: 2nd perfusion of ketamine | Arm Label: Placebo/Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of saline, Other: Follow-up between perfusions, Drug: 2nd perfusion of saline | Intervention Type: OTHER; Name: Baseline evaluation; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 1st perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 1st perfusion of saline; Assigned to Arm(s): Placebo/Control | Intervention Type: OTHER; Name: Follow-up between perfusions; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 2nd perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 2nd perfusion of saline; Assigned to Arm(s): Placebo/Control
B: Arm Label: Compassion meditation (CM); Type: EXPERIMENTAL; Interventions: Behavioral: Compassion meditation (CM) | Arm Label: Support group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group (SG) | Intervention Type: BEHAVIORAL; Name: Compassion meditation (CM); Assigned to Arm(s): Compassion meditation (CM) | Intervention Type: BEHAVIORAL; Name: Support group (SG); Assigned to Arm(s): Support group (SG)
C: Arm Label: Intervention Group ASSIP; Type: EXPERIMENTAL; Interventions: Behavioral: Attempted Suicide Short Intervention Program (ASSIP) | Arm Label: Control Group CG; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group (CG) | Intervention Type: BEHAVIORAL; Name: Attempted Suicide Short Intervention Program (ASSIP); Assigned to Arm(s): Intervention Group ASSIP | Intervention Type: BEHAVIORAL; Name: Control Group (CG); Assigned to Arm(s): Control Group CG
D: Arm Label: Caring Letter Condition (CL); Type: EXPERIMENTAL; Interventions: Behavioral: Caring Letter (email) | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Caring Letter (email); Assigned to Arm(s): Caring Letter Condition (CL)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans
Brief Summary: The purpose of this study is to conduct a pilot randomized controlled trial (RCT) with low-income, suicidal African American women and men that compares the relative effectiveness of compassion meditation (CM) versus a support group (SG) .


Options:
A: Arm Label: Fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluoxetine, Drug: Citalopram | Arm Label: Dialectical behavior therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical behavior therapy | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): Fluoxetine
B: Arm Label: Compassion meditation (CM); Type: EXPERIMENTAL; Interventions: Behavioral: Compassion meditation (CM) | Arm Label: Support group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group (SG) | Intervention Type: BEHAVIORAL; Name: Compassion meditation (CM); Assigned to Arm(s): Compassion meditation (CM) | Intervention Type: BEHAVIORAL; Name: Support group (SG); Assigned to Arm(s): Support group (SG)
C: Arm Label: Adjunctive Internet-delivered ERITA; Type: EXPERIMENTAL; Interventions: Behavioral: Emotion regulation individual therapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Emotion regulation individual therapy; Assigned to Arm(s): Adjunctive Internet-delivered ERITA | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Arm Label: Care Management; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management | Arm Label: Skills Training; Type: EXPERIMENTAL; Interventions: Behavioral: Skills Training | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Care Management; Assigned to Arm(s): Care Management | Intervention Type: BEHAVIORAL; Name: Skills Training; Assigned to Arm(s): Skills Training | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans
Brief Summary: The purpose of this study is to conduct a pilot randomized controlled trial (RCT) with low-income, suicidal African American women and men that compares the relative effectiveness of compassion meditation (CM) versus a support group (SG) .


Options:
A: Arm Label: Telephone-based management; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual | Arm Label: iFightDepression for Suicide; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Telephone-based management, Behavioral: iFightDepression for Suicide | Arm Label: Self Awareness of Mental Health; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual, Behavioral: Self Awareness of Mental Health | Intervention Type: BEHAVIORAL; Name: Telephone-based management; Assigned to Arm(s): Treatment as Usual | Intervention Type: BEHAVIORAL; Name: iFightDepression for Suicide; Assigned to Arm(s): Treatment as Usual | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Self Awareness of Mental Health, Telephone-based management, iFightDepression for Suicide | Intervention Type: BEHAVIORAL; Name: Self Awareness of Mental Health; Assigned to Arm(s): Self Awareness of Mental Health
B: Arm Label: Attachment Based Family Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Attachment Based Family Therapy | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Attachment Based Family Therapy; Assigned to Arm(s): Attachment Based Family Therapy | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
C: Arm Label: Compassion meditation (CM); Type: EXPERIMENTAL; Interventions: Behavioral: Compassion meditation (CM) | Arm Label: Support group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group (SG) | Intervention Type: BEHAVIORAL; Name: Compassion meditation (CM); Assigned to Arm(s): Compassion meditation (CM) | Intervention Type: BEHAVIORAL; Name: Support group (SG); Assigned to Arm(s): Support group (SG)
D: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants

Answer: C